# US 2026/0110023 A1 · Methods for fast nucleic acid amplification

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0110023 A1
- Document ID: US20260110023A1
- Status: Published application
- Kind: A1
- Application number: 19/423,536
- Filed: 2025-12-17
- Published: 2026-04-23
- Earliest claimed: 2012-05-24
- Assignees: University of Utah Research Foundation
- Applicants: University of Utah Research Foundation
- Inventors: Carl T. Wittwer; Jared Steven Farrar
- Web page: https://patentgrep.com/patent/US20260110023A1

## CPC

- C12Q 1/686: Polymerase chain reaction [PCR]
- B01L 7/02: Water baths; Sand baths; Air baths
- B01L 7/52: {with provision for submitting samples to a predetermined sequence of different temperatures, e.g. for treating nucleic acid samples}
- B01L 7/5255: {by moving sample containers}
- B01L 3/5027: {by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip}
- B01L 2200/06: Fluid handling related problems
- B01L 2300/0627: Sensor or part of a sensor is integrated
- B01L 2300/1894: Cooling means; Cryo cooling
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- B01L: CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE

## Abstract

Methods, devices, and kits are provided for performing PCR in <20 seconds per cycle, with improved efficiency and yield.

## Claims

### Claim 1

A method for amplifying a target nucleic acid sequence in a biological sample during amplification comprising the steps of:
adding a thermostable polymerase and primers configured for amplification of the target nucleic acid sequence to the biological sample, wherein the polymerase is provided at a concentration in a range of about 0.4-12 U/μl and primers are each provided at a concentration in a range of about 1.5-20 μM; and
amplifying the target nucleic acid sequence by polymerase chain reaction by thermally cycling the biological sample between at least a denaturation temperature and an elongation temperature through a plurality of amplification cycles using an extreme temperature cycling profile wherein each cycle is completed in a cycle time less than 20 seconds per cycle.

### Claim 2 (depends on 1)

The method of claim 1, wherein each cycle is completed in less than 2 seconds per cycle.

### Claim 3 (depends on 1)

The method of claim 1, wherein the ramp rate is at least 200° C./s.

### Claim 4 (depends on 3)

The method of claim 3, wherein the ramp rate is at least 300° C./s.

### Claim 5 (depends on 4)

The method of claim 4, wherein the ramp rate is at least 400° C./s.

### Claim 6 (depends on 1)

The method of claim 1, wherein the plateau is at least 20 cycles after Cp.

### Claim 7 (depends on 1)

The method of claim 1, wherein the concentration for each primer is greater than 2.5 μM.

### Claim 8 (depends on 1)

The method of claim 1,
further comprising an annealing temperature that is different from the elongation temperature,
wherein the amplifying step generates an amplicon greater than 100 bp, and
wherein the extreme temperature cycling profile includes a hold at the elongation temperature of a time about equal to extension length (amplicon length-primer length) in base pairs divided by an extension rate of the thermostable polymerase in bases/second.

### Claim 9 (depends on 1)

The method of claim 1, wherein the amplifying step further includes an annealing temperature which is the same or lower than the elongation temperature, and
the amplifying step includes a hold of 0.05 to 0.9 seconds at the annealing temperature.

### Claim 10 (depends on 1)

The method of claim 1, wherein the Mg++ concentration is at least 4 mM.

### Claim 11 (depends on 1)

The method of claim 1, wherein the polymerase and primer concentrations are increased by a factor and the cycle time is divided by the factor.

### Claim 12 (depends on 1)

The method of claim 1, wherein the extreme temperature profile includes an annealing time defined by
annealing time=k1/[primer]
wherein k1 is a constant, and
[primer] is the concentration of each primer.

### Claim 13 (depends on 12)

The method of claim 12, wherein k1 is experimentally determined.

### Claim 14 (depends on 1)

The method of claim 1, wherein the temperature cycling profile includes a time at the elongation temperature defined by
elongation time=k2(extension length)/([polymerase]*(polymerase speed))
wherein k2 is a proportionality constant,
[polymerase] is the concentration of the polymerase, and
polymerase speed is a rate of polymerase incorporation of bases in nucleotides/s.

### Claim 15 (depends on 14)

The method of claim 14, wherein k2 is experimentally determined.

### Claim 16 (depends on 1)

The method of claim 1, wherein the target nucleic acid is amplified with an efficiency of at least 70%.

### Claim 17

A method for amplifying a target nucleic acid sequence in a biological sample during amplification comprising the steps of:
adding a thermostable polymerase and primers configured for amplification of the target nucleic acid sequence to the biological sample, wherein the polymerase to primer ratio is (about 0.03 to about 0.4 polymerase):(total primer concentration), and the polymerase concentration is provided in a range of about 0.4-12 U/μl; and
amplifying the target nucleic acid sequence by polymerase chain reaction by thermally cycling the biological sample between at least a denaturation temperature and an elongation temperature through a plurality of amplification cycles using an extreme temperature cycling profile wherein each cycle is completed in less than 20 seconds.

### Claim 18 (depends on 17)

The method of claim 17, wherein each cycle is completed in less than 10 seconds.

### Claim 19 (depends on 18)

The method of claim 18, wherein each cycle is completed in less than 5 seconds.

### Claim 20 (depends on 19)

The method of claim 19, wherein each cycle is completed in less than 2 seconds.

### Claim 21 (depends on 17)

The method of claim 17, wherein the target nucleic acid is genomic DNA.

### Claim 22 (depends on 17)

The method of claim 17, wherein the biological sample contains eukaryotic genomic DNA.

### Claim 23 (depends on 17)

The method of claim 17, wherein the polymerase is KlenTaq provided at a concentration of at least 0.8 U/μl.

### Claim 24 (depends on 17)

The method of claim 17, wherein non-specific amplification is below detectible levels.

### Claim 25 (depends on 17)

The method of claim 17, wherein total primer concentration is at least 5 μM.
